- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06675721
A Survey of Acceptance and Factors Associated With Hesitancy Vaccination in Northeast Brazil
A Survey of Acceptance and Factors Associated With Hesitancy Vaccination in a Socioeconomically Disadvantaged Population and Professionals Working in a City Located in Northeast Brazil
The objective of this study is to investigate vaccination acceptance and identify the reasons why people are not vaccinated.
People over 18 years of age who live in neighborhoods with socioeconomic vulnerability and with many cases of infectious diseases, as well as health professionals, will respond to a research questionnaire.
Study Overview
Status
Conditions
Intervention / Treatment
Study Type
Enrollment (Estimated)
Contacts and Locations
Study Contact
- Name: Kleber G Luz, PhD
- Phone Number: +55 84 999824374
- Email: klebergluz@gmail.com
Study Contact Backup
- Name: Eveline P Milan, PhD
- Phone Number: +55 84 994027404
- Email: evepipolo@gmail.com
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Sampling Method
Study Population
Vulnerable populations residing in neighborhoods characterized by socioeconomic vulnerability and high infectious disease incidence. Four neighborhoods in Natal will be the focus, each with their respective population: Lagoa Azul (61,289), Pajuçara (58,021), Felipe Camarão (50,997), and Planalto (31,206).
In this project, the inclusion of health professionals as a unified group is essential because of their critical role as trusted source of health information. In Natal, these professionals consist of 5,238 physicians and an estimated 7,066 nurses (derived from a 61.6% prevalence applied to the 11,471 registered nurses in Rio Grande do Norte).
Description
Inclusion Criteria:
- Individuals who are over 18 years old and are residents of the PAJUÇARA, FELIPE CAMARÃO, LAGOA AZUL, or PLANALTO neighborhoods, willing to answer the study questionnaire.
- Healthcare professionals who work in Natal, willing to answer the study questionnaire.
Study Plan
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
|---|---|
|
Vulnerable group
Individuals who are over 18 years old and are residents of the socioeconomically vulnerable neighborhoods.
|
A survey questionnaire to assess factors related to vaccination adherence, including factors such as vaccine novelty, cost, and prior knowledge among vulnerable populations.
|
|
Health Professionals
Healthcare professionals who work in Natal.
|
A survey questionnaire to assess factors related to vaccination adherence, including factors such as vaccine novelty, cost, and prior knowledge among vulnerable populations.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Resistance to adherence to vaccination
Time Frame: Baseline
|
Resistance to adherence to vaccination will be measured using a questionnaire developed for this survey.
The questionnaire will be described by mean and standard deviation, and the distribution frequency of each item will be presented, comparing cohorts of health professionals and populations in socioeconomic vulnerability.
|
Baseline
|
Collaborators and Investigators
Collaborators
Investigators
- Principal Investigator: Kleber G Luz, PhD, Centro de Estudos e Pesquisas em Moléstias Infecciosas
Study record dates
Study Major Dates
Study Start (Estimated)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimated)
Study Record Updates
Last Update Posted (Estimated)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Other Study ID Numbers
- EII1001HEVANO
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.